The commentary, authored by Sasikanth Gorantla of the Emory University School of Medicine, Katyayini Aribindi of the University of California, Davis, and Vishesh K. Kapur of the University of Washington School of Medicine, responds to a population-based cohort study showing that sleep homeostasis is impaired across the full spectrum of obstructive sleep apnea severity. That finding, the authors contend, elevates sleep homeostasis from an abstract concept of sleep science to a measurable clinical signal, one that could reshape how researchers and physicians evaluate the burden of the disease and the success of its treatment.

Sleep homeostasis is one half of the classic two-process model of sleep regulation, first articulated by Alexander Borbély in 1982. The model holds that sleep timing and depth are governed by the interaction of a circadian process, which rhythms sleep and wakefulness across the day, and a homeostatic process, an hourglass-like accumulation of sleep need that builds during waking hours and dissipates during sleep. The electrophysiological signature of this homeostatic process is most visible in the electroencephalogram as slow-wave activity, the low-frequency delta power that dominates deep non-REM sleep and declines progressively across a night of rest.

Decades of research in animal models and humans have established that this slow-wave signature is not merely a byproduct of sleep but a reflection of genuine neurophysiological work. Studies of freely behaving rats by Vyazovskiy, Cirelli and Tononi demonstrated that the electrophysiological correlates of sleep homeostasis are tightly linked to the duration of prior wakefulness. The influential synaptic homeostasis hypothesis proposed by Tononi and Cirelli goes further, suggesting that slow-wave activity during sleep actively downscales synapses strengthened during wakefulness, protecting neural circuits from saturation and preserving the brain’s capacity for plasticity, learning and memory consolidation.

Against this backdrop, the notion that obstructive sleep apnea disrupts sleep homeostasis takes on considerable significance. The disorder fragments sleep with repeated collapses of the upper airway, each accompanied by oxygen desaturation and an arousal that shatters the continuity of deep sleep. But the commentary emphasizes that the damage is not simply a matter of sleep loss. The recurring hypoxic and ventilatory stresses of apnea appear to interfere with the very mechanisms that generate and dissipate homeostatic sleep pressure, leaving patients with a brain that has neither slept deeply enough nor recovered adequately, even after nights that seem, on paper, to contain sufficient hours of sleep.

Recent landmark studies have already shown why conventional indices fall short. The hypoxic burden of sleep apnea, a measure of the severity of oxygen deprivation rather than the frequency of breathing events, predicted cardiovascular disease-related mortality in large cohorts including the Osteoporotic Fractures in Men Study and the Sleep Heart Health Study. Similarly, ventilatory burden, which quantifies the respiratory effort expended against a collapsed airway, proved predictive of cardiovascular and all-cause mortality in work published in the American Journal of Respiratory and Critical Care Medicine. These alternative measures capture physiological stress that the apnea-hypopnea index misses, and sleep homeostasis, the commentary argues, belongs squarely in this emerging family of clinically meaningful severity markers.

The implications for treatment evaluation are particularly striking. Continuous positive airway pressure, the standard therapy for obstructive sleep apnea, has produced famously mixed results in trials of neurocognitive outcomes, including the large APPLES study, and real-world registry data on its effect on sleepiness reveal variable benefit. The commentary notes that sleep architecture impairment and cognitive performance vary substantially across apnea phenotypes, and that conventional polysomnographic outcomes may be too blunt to detect which patients genuinely recover restorative sleep under therapy. Quantifying slow-wave activity and other markers of homeostatic sleep regulation could provide a sensitive readout of whether treatment is actually restoring the brain’s recovery processes, not merely eliminating respiratory events.

The commentary also situates sleep homeostasis within a broader neurophysiological context. Recent imaging work in humans has revealed coupled electrophysiological, hemodynamic and cerebrospinal fluid oscillations during sleep, suggesting that slow-wave activity coordinates a large-scale clearance and restoration program in the brain. Pharmacological studies complicate the picture further: caffeine reduces low-frequency delta activity in the sleep EEG, benzodiazepines such as temazepam alter slow waves in ways that do not necessarily restore normal homeostatic function, and antidepressants including fluoxetine and trazodone reshape sleep architecture with distinct effects on slow-wave activity. Any clinical use of sleep homeostasis as an outcome measure will therefore need to account for these pharmacological and physiological confounders.

For the field of sleep medicine, the commentary’s central message is one of expansion rather than replacement. The apnea-hypopnea index remains useful for diagnosis and disease classification, but it was never designed to capture the neurophysiological consequences of the disorder. Sleep homeostasis, measurable through standard EEG recordings and increasingly through high-density and quantitative EEG techniques, offers a patient-centered, mechanism-based outcome that aligns with what patients and clinicians ultimately care about: whether the brain is recovering night after night. If validated in prospective trials, this measure could help stratify patients, personalize therapy and provide a more faithful endpoint for the next generation of apnea treatments.

The work received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. As sleep researchers continue to refine how obstructive sleep apnea is defined and staged, the humble delta wave, once an academic curiosity of sleep physiology, may prove to be one of the most informative signals a clinician can read from a sleeping patient’s brain, a direct measure of the homeostatic machinery that obstructive sleep apnea quietly wears down.

Subject of Research: Sleep homeostasis as a neurophysiological outcome measure in obstructive sleep apnea

Article Title: Sleep homeostasis in OSA: a complementary neurophysiological outcome measure

Article References: Gorantla, S., Aribindi, K., & Kapur, V. K. (2026). Sleep homeostasis in OSA: a complementary neurophysiological outcome measure. Journal of Clinical Sleep Medicine, 22(1), Article 157. https://doi.org/10.1007/s44470-026-00174-9

Image Credits: AI Generated

DOI: 10.1007/s44470-026-00174-9

Keywords: obstructive sleep apnea, sleep homeostasis, slow-wave activity, two-process model, EEG delta power, apnea-hypopnea index, hypoxic burden, ventilatory burden, CPAP treatment, synaptic homeostasis hypothesis, sleep architecture, cognitive performance